Gsk

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• LIST INGRE2 refused lines

  Ingredients not listed

  The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

• NCONTACT1 refused line

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

Questions about Gsk

Is Gsk on an FDA import alert?

No listing for Gsk appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the United Kingdom page.

Has FDA refused shipments from Gsk?

Yes. FDA refused 2 shipment lines from Gsk between June 13, 2023 and September 21, 2023. The most recent, on September 21, 2023, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as LIST INGRE (ingredients not listed).

Why did FDA refuse Gsk's shipments?

The most frequent charges are LIST INGRE (ingredients not listed, 2 lines) and NCONTACT (no u.s. adverse event contact on supplement label, 1 line).

What is Gsk's FEI number?

Gsk's FDA Establishment Identifier (FEI) is 3005979656.